ライフサイエンス機器の市場規模：技術別、用途別、エンドユーザー別、地域範囲別、予測

ライフサイエンス機器の世界市場規模と予測

ライフサイエンス機器の世界市場規模は、2024年に622億4,000万米ドルと評価され、2026～2032年にかけてCAGR 4.70%で成長し、2032年には869億米ドルに達すると予測されています。

ライフサイエンス機器とは、生物学や生物医療の研究において、生物やプロセスを調査するために使用されるツールや機器を指します。顕微鏡、分光学、クロマトグラフィー、分子分析機器などが含まれ、遺伝学、生理学、薬理学などの領域の知識を向上させるために不可欠です。

ライフサイエンス機器は、研究、診断、医薬品開発に不可欠です。DNAシーケンス、細胞イメージングのための顕微鏡検査、分子分離のためのクロマトグラフィー、生体分子定量化のための分光光度計などの技術を用いて、生物学的サンプルを正確に研究することができます。

ライフサイエンス機器は、研究、診断、治療において進化し続けると考えられます。将来の用途には、精密医療ツール、個別化ゲノム研究のための高性能シーケンス、超解像顕微鏡などの強化されたイメージング技術、リアルタイムの健康モニタリングや環境分析のためのバイオセンサなどが含まれます。

ライフサイエンス機器の世界市場力学

世界のライフサイエンス機器市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

バイオ医薬品の研究開発：バイオ医薬品の研究開発：革新的な治療法や治療法に対する需要の高まりから、特にバイオ医薬品がライフサイエンス機器の強化の必要性を高めています。この産業は、医薬品開発、遺伝学、プロテオミクス、オーダーメイド医療のためのツールに大きく依存しています。

ヘルスケア支出と研究資金：ヘルスケア研究開発への政府と民間投資は、ライフサイエンス機器市場に大きな影響を与えています。学術研究、研究開発、病院インフラへの資金提供は、機器の導入率に直接的な影響を与えます。

臨床診断における用途の増加：ライフサイエンス機器は、診断目的で臨床現場で使用されることが増えています。分子診断、病理学、遺伝子検査用の機器は、病気の発見、治療法の選択、モニタリングにおいてますます重要性を増しています。

主要課題

規制遵守：ライフサイエンスセグメントの機器は、厳しい精度、信頼性、安全基準を満たさなければなりません。様々な規制の枠組みを乗り越えることは、メーカーにとって難しい課題です。

コスト圧力：先進的な機器の開発には、研究開発に多額の投資を必要とすることが多いです。技術革新に対する需要と、コスト効率の高い製造・価格設定方法とのバランスをとることは、大きな課題です。

世界的競合：市場は非常に競争が激しく、既存企業も新興企業も市場シェアを争っています。熾烈な世界競争に直面すると、革新性、性能、サービスに基づいて製品を差別化することが難しくなる可能性があります。

主要動向

個別化医療への需要：ゲノム分析ツールや個別化治療を可能にする診断ツールなど、個別化医療技術をサポートする機器へのニーズが高まっています。

研究開発投資の増加：官民ともにライフサイエンス研究開発への投資を増やしており、学術、製薬、バイオテクノロジーセグメントの機器需要を押し上げています。

自動化と統合：ワークフローの自動化と機器とデータ分析システムの統合が進んでいます。この動きは、手順の合理化、人為的ミスの排除、データ管理能力の強化を目指すものです。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主要調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 ライフサイエンス機器市場：技術別

• 分光法
• クロマトグラフィー
• ポリメラーゼ連鎖反応
• 免疫測定
• 凍結乾燥
• リキッドハンドリングシステム
• 臨床化学分析機器
• 顕微鏡検査
• フローサイトメトリー
• 次世代シーケンサー（NGS）
• 遠心分離機
• 電気泳動

第5章 ライフサイエンス機器市場：用途別

• 研究用途
• 臨床・診断用途

第6章 ライフサイエンス機器市場：エンドユーザー別

• 病院と診断ラボ
• 製薬・バイオテクノロジー企業
• 学術・研究機関
• 農業・食品産業
• 環境検査ラボ
• 臨床研究機関

第7章 地域分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Danaher
• Thermo Fisher Scientific, Inc.
• Merck & Co., Inc.
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Illumina Inc.
• PerkinElmer, Inc.
• BD
• Bruker
• Hitachi High-Technologies Corporation
• Among others

第11章 市場展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 供給源と参考文献

Global Life Science Instrumentation Market Size and Forecast

Global Life Science Instrumentation Market size was valued at USD 62.24 Billion in 2024 and is projected to reach USD 86.9 Billion by 2032 growing at a CAGR of 4.70% from 2026 to 2032.

Life Science Instrumentation refers to the tools and equipment used in biological and biomedical research to investigate living creatures and processes. It includes microscopy, spectroscopy, chromatography and molecular analysis instruments that are critical for improving knowledge in domains such as genetics, physiology and pharmacology.

Life science apparatus is critical for research, diagnosis and medication development. It allows for exact study of biological samples using techniques such as DNA sequencing, microscopy for cellular imaging, chromatography for molecule separation and spectrophotometry for biomolecule quantification.

Life science instruments will continue to evolve in research, diagnostics and therapies. Future applications include precision medical tools, high-throughput sequencing for personalized genomics, enhanced imaging techniques such as super-resolution microscopy and biosensors for real-time health monitoring and environmental analysis.

Global Life Science Instrumentation Market Dynamics

The key market dynamics that are shaping the global life science instrumentation market include:

Key Market Drivers:

Biopharmaceutical Research and Development: The growing demand for innovative treatments and cures notably biopharmaceuticals, drives the need for enhanced life science apparatus. This industry relies heavily on tools for drug development, genetics, proteomics and customized medicine.

Healthcare Expenditure and Research Funding: Government and private-sector investments in healthcare R&D have a substantial impact on the life science instruments market. Funding for academic research, pharmaceutical development and hospital infrastructure have a direct impact on instrument adoption rates.

Rising Applications in Clinical Diagnostics: Life science equipment are increasingly being used in clinical settings for diagnostic purposes. Instruments for molecular diagnostics, pathology and genetic testing are becoming increasingly significant in illness detection, therapy selection and monitoring.

Key Challenges:

Regulatory Compliance: Instruments in the life sciences field must meet stringent accuracy, reliability and safety standards. Navigating various regulatory frameworks can be challenging for manufacturers.

Cost Pressures: Developing advanced instruments frequently necessitates significant investment in research and development. Balancing the demand for innovation with cost-effective manufacturing and pricing methods presents a considerable challenge.

Global Competition: The market is extremely competitive, with both established corporations and start-ups competing for market share. In the face of fierce global competition, it can be difficult to differentiate products based on innovation, performance and service.

Key Trends:

Demand for Customized Medical: There is an increasing need for instruments that support customized medical techniques, such as genomic analysis tools and diagnostic tools that allow for individualized treatment options.

Increasing R&D Investments: Both the public and commercial sectors are investing more in life sciences research and development, which is driving up demand for instrumentation in the academic, pharmaceutical and biotechnology sectors.

Automation and Integration: Workflow automation and instrument integration with data analytics systems are on the rise. This movement seeks to streamline procedures, eliminate human error and enhance data management capabilities.

Global Life Science Instrumentation Market Regional Analysis

Here is a more detailed regional analysis of the global life science instrumentation market:

North America:

According to Verified Market Research, North America is expected to dominate the global life science instrumentation market.

North America presently dominates the Life Science Instrumentation market for numerous reasons. The region includes a large concentration of pharmaceutical and biotechnology businesses, considerable R&D activity, advanced healthcare infrastructure and strong regulatory frameworks that encourage innovation.

Strong connections between academia and industry also help the market maintain its leadership position.

North America's position is further strengthened by considerable investments in cutting-edge technologies such as next-generation sequencing, advanced imaging systems and automated laboratory instruments, which ensures continuing growth and competitiveness in the global life science instrumentation industry.

Asia Pacific:

According to Verified Market Research, Asia Pacific is fastest growing region in global life science instrumentation market.

Asia-Pacific (APAC) is emerging as the most rapidly increasing region in the Life Science Instrumentation industry.

Increasing healthcare spending, expanding pharmaceutical and biotechnology sectors and rising use of advanced research technologies in nations such as China, India and Japan are all driving the expansion.

APAC benefits from a greater focus on precision medicine and individualized healthcare solutions, as well as supportive government initiatives and expenditures in research infrastructure. APAC will continue to be a significant growing market for life science instrumentation in the future years.

Global Life Science Instrumentation Market: Segmentation Analysis

The Global Life Science Instrumentation Market is segmented based on End User, Technology, Application and Geography.

Global Life Science Instrumentation Market, By Technology

• Spectroscopy
• Chromatography
• Polymerase Chain Reaction
• Immunoassays
• Lyophilization
• Liquid Handling Systems
• Clinical Chemistry Analyzers
• Microscopy
• Flow Cytometry
• Next-Generation Sequencing (NGS)
• Centrifuges
• Electrophoresis

Based on Technology, the Global Life Science Instrumentation Market is separated into Spectroscopy, Chromatography, Polymerase Chain Reaction, Immunoassays, Lyophilization, Liquid Handling Systems, Clinical Chemistry Analyzers, Microscopy, Flow Cytometry, Next-Generation Sequencing (NGS), Centrifuges, Electrophoresis. Next-Generation Sequencing (NGS) technology changed genomics research and personalized treatment, and it now leads the Global Life Science Instrumentation Market. It enables high-throughput DNA and RNA sequencing, which benefits industries like as cancer diagnosis, infectious disease research and agricultural genomics. NGS instruments provide remarkable scalability, speed and cost-efficiency as compared to older approaches. This technological improvement generates significant demand, which is supported by ongoing innovation and applications in biotechnology, pharmaceuticals and academic research.

Global Life Science Instrumentation Market, By Application

• Research Applications
• Clinical & Diagnostics Applications

Based on Application, Global Life Science Instrumentation Market is divided into Research Applications and Clinical & Diagnostics Applications. Clinical and diagnostics applications account for the majority of the global life science instrumentation market. This sector includes tools used in medical laboratories, hospitals and diagnostic centers to diagnose diseases, monitor patients and evaluate treatments. The need is being fueling by rising healthcare costs, aging populations and advances in diagnostic technology. While important, research applications involve a broader range of scientific discovery and development, including medication discovery, biotechnology research and academic study.

Global Life Science Instrumentation Market, By End-User

• Hospitals and Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Agriculture & Food Industries
• Environmental Testing Laboratories
• Clinical Research Organizations

Based on End-User, Global Life Science Instrumentation Market is divided into Hospitals and Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Agriculture & Food Industries, Environmental Testing Laboratories, Clinical Research Organizations. Pharmaceutical & Biotechnology Companies dominate the global life science instrumentation market due to their considerable use in modern equipment for drug research, development and quality assurance. Academic and research institutes follow, promoting innovation and technological acceptance. Hospitals and diagnostic laboratories use instrumentation for diagnostics, whereas Clinical Research Organizations play an important role in clinical trials. Agriculture and food industries, as well as environmental testing laboratories supply specialized devices for quality assessment and monitoring.

Global Life Science Instrumentation Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the market divided into North America, Europe, Asia Pacific and Rest of the World. North America leads the Global Life Science Instrumentation Market owing to its concentration of pharmaceutical and biotechnology companies, significant R&D investments, sophisticated healthcare infrastructure and favorable regulatory environment. Europe follows closely with a strong foundation of academic research and technical innovation. Asia Pacific is seeing significant expansion, driven by rising healthcare spending, expanding biotech sectors and growing acceptance of innovative technologies. The Rest of the World area displays diverse market dynamics shaped by regional economic variables and healthcare trends.

Key Players

• The Global Life Science Instrumentation Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are Danaher, Thermo Fisher Scientific, Inc., Merck & Co., Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina Inc., PerkinElmer, Inc., BD, Bruker, Hitachi High-Technologies Corporation among others

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Global Life Science Instrumentation Market Recent Developments
• In June 2022, Agilent Technologies introduced new liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS) quadrupole mass spectrometers. The company claims that these instruments will improve instrument intelligence and diagnostics, leading to increased system uptime for customers.
• In March 2022, Shimadzu Europe announced the availability of the IRXross Fourier-transform infrared (FTIR) spectrometer. This mid-level FTIR equipment offers superior performance, including high S/N ratio, resolution, measurement speed, and ease of use.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Life Science Instrumentation Market, By Technology

• Spectroscopy
• Chromatography
• Polymerase Chain Reaction
• Immunoassays
• Lyophilization
• Liquid Handling Systems
• Clinical Chemistry Analyzers
• Microscopy
• Flow Cytometry
• Next-Generation Sequencing (NGS)
• Centrifuges
• Electrophoresis

5. Life Science Instrumentation Market, By Application

• Research Applications
• Clinical & Diagnostics Applications

6. Life Science Instrumentation Market, By End-User

• Hospitals and Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Agriculture & Food Industries
• Environmental Testing Laboratories
• Clinical Research Organizations

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Danaher
• Thermo Fisher Scientific, Inc.
• Merck & Co., Inc.
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Illumina Inc.
• PerkinElmer, Inc.
• BD
• Bruker
• Hitachi High-Technologies Corporation
• Among others

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References